BackNeoCore Technology , Ltd. Overview

NeoCore Technology , Ltd. Net Tangible Assets

NeoCore Technology , Ltd.'s net tangible assets is $310M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$306.87M
↓ 7.48% YoYΔ $-24.82M vs prior year quarter

Peer trimmed avg / median

Loading

NeoCore Technology , Ltd. Net Tangible Assets History

Loading

NeoCore Technology , Ltd. vs. peers: Net Tangible Assets Comparison

Loading

NeoCore Technology , Ltd. Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NeoCore Technology , Ltd. (4131.TWO) FAQ

The latest net tangible assets for 4131.TWO is $310M as of June 2026. That compares with $330M in the prior-year period — down 7.5% year over year. Investors often review this figure alongside NeoCore Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4131.TWO's net tangible assets moved from $330M to $310M — a 7.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeoCore Technology , Ltd.'s operating scale or balance-sheet position.

A net tangible assets figure of $310M for 4131.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4131.TWO's net tangible assets ($310M), review year-over-year change from $330M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NeoCore Technology , Ltd.'s net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.